A Value Set for the EQ-5D Based on Experienced Health States
暂无分享,去创建一个
[1] George Loewenstein,et al. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public , 2003, Quality of Life Research.
[2] D. Feeny,et al. Do They Have a Role in the Measurement of Preferences for Health States , 2001 .
[3] P. Dolan,et al. The time trade-off method: results from a general population study. , 1996, Health economics.
[4] W. Greiner,et al. Die deutsche Version des EuroQol-Fragebogens , 1998, Zeitschrift für Gesundheitswissenschaften = Journal of public health.
[5] R. Leidl,et al. [Health status of adults in Germany: results from a representative survey using the EuroQol 5D (EQ-5D)]. , 2010, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[6] Josep Maria Haro,et al. Comparison of Population Health Status in Six European Countries: Results of a Representative Survey Using the EQ-5D Questionnaire , 2009, Medical care.
[7] A. Brennan,et al. Should patients have a greater role in valuing health states? , 2005, Applied health economics and health policy.
[8] J. Brazier,et al. A comparison of patient and general population weightings of EQ-5D dimensions. , 2009, Health economics.
[9] D. Kahneman,et al. Interpretations of Utility and Their Implications for the Valuation of Health , 2008 .
[10] Anirban Basu,et al. A linear index for predicting joint health-states utilities from single health-states utilities. , 2009, Health economics.
[11] A. Mielck,et al. Gesundheitszustand bei Erwachsenen in Deutschland: Ergebnisse einer repräsentativen Befragung mit dem EuroQol 5D (EQ-5D) , 2010 .
[12] D. Street,et al. International comparisons in valuing EQ-5D health states: a review and analysis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] Peep F M Stalmeier,et al. Inconsistencies in TTO and VAS Values for EQ-5D Health States , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] H. Hahmann,et al. Validation of the EuroQol questionnaire in cardiac rehabilitation , 2005, Heart.
[15] Frank de Charro,et al. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective , 2003, Springer Netherlands.
[16] Andrew Lloyd,et al. Health Utilities Using the EQ-5D in Studies of Cancer , 2012, PharmacoEconomics.
[17] M. Zeegers,et al. A meta-analysis demonstrates no significant differences between patient and population preferences. , 2006, Journal of clinical epidemiology.
[18] W. Greiner. A European EQ-5D VAS valuation set , 2003 .
[19] R. Leidl. Preferences, quality of life and public health. , 2009, European journal of public health.
[20] David Parkin,et al. Is there a case for using visual analogue scale valuations in cost-utility analysis? , 2006, Health economics.
[21] G Loomes,et al. Visual Analog Scales, Standard Gambles, and Relative Risk Aversion , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] A. Bagust,et al. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. , 2005, Health economics.
[23] M. Weinstein,et al. QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[24] A. Stiggelbout,et al. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] Jeffrey A. Johnson,et al. Relative Efficiency of the EQ-5D, HUI2, and HUI3 Index Scores in Measuring Health Burden of Chronic Medical Conditions in a Population Health Survey in the United States , 2009, Medical care.
[26] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[27] H. König,et al. Validity, reliability, and responsiveness of the EQ‐5D in inflammatory bowel disease in Germany , 2010, Inflammatory bowel diseases.
[28] R. de Graaf,et al. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] W. Greiner,et al. Validating the EQ-5D with time trade off for the German population , 2005, The European Journal of Health Economics.
[30] Christopher McCabe,et al. Multi-attribute utility function or statistical inference models: a comparison of health state valuation models using the HUI2 health state classification system. , 2007, Journal of health economics.